Strategy and Portfolio

1.Medical Need Products
by own research, development and registration.

2. Clinical Trial Medication (Sponsors)
Production of medication for clinical trails
• EU-GMP license 109098 F
• Appointed Laboratory 4133 ALAB
• State of the art facility
• Small, dedicated organisation (people)

Di-Adreson-F aquosum to remain available

28 June 2010

ACE Pharmaceuticals BV signed an agreement with MSD for the transfer of the marketing authorization Di-Adreson^®-F aquosum.

Levamisole trial progress

12 April 2010

In March 2010 the 50th patient has been included in the Levamisole trial.

Skating clinic ACE Pharmaceuticals BV

27 October 2009

In February 2009 employees of ACE participated in a skating clinic.